home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5 rows where docket_id = "FDA-2006-P-0150" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

  • 2006 2
  • 2008 2
  • 2010 1

document_type 2

  • Other 4
  • Supporting & Related Material 1

agency_id 1

  • FDA 5
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-P-0150-0005 FDA FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 Citizen Petition Approval from FDA CDER to Lachman Consultant Services, Inc. Other Approval 2010-12-14T05:00:00Z 2010 12 2010-12-14T05:00:00Z   2025-01-07T15:29:36Z   0 0 0900006480bb6370
FDA-2006-P-0150-0004 FDA FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 Citizen Petition Amendment from Lachman Consultant Services, Inc. Other Amendment 2008-05-06T04:00:00Z 2008 5 2008-05-06T04:00:00Z   2025-01-07T15:27:26Z   0 0 090000648054bf90
FDA-2006-P-0150-0003 FDA FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 Citizen Petition from Lachman Consultant Services, Inc. Other Citizen Petition 2008-05-06T04:00:00Z 2008 5 2008-05-06T04:00:00Z   2025-01-07T15:25:35Z   0 0 0900006480450517
FDA-2006-P-0150-0001 FDA FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 Acknowledgement Letter from FDA DMB to Lachman Consultant Services, Inc. Other Acknowledgement Letter/Receipt 2006-01-06T05:00:00Z 2006 1     2025-01-07T15:22:33Z   0 0 090000648045050e
FDA-2006-P-0150-0002 FDA FDA to declare that Methocarbamol Tablets USP, 1000 mg is suitable for submission as an ANDA-CLOSED FDA-2006-P-0150 DUPLICATE TO Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc. Supporting & Related Material Acknowledgement Letter/Receipt 2006-01-06T05:00:00Z 2006 1     2025-01-07T15:32:59Z   0 0 0900006480450518

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 2611.918ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API